- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Lifecare ASA: Minutes from Annual General Meeting | - | Oslo Børs | ||
| Mi | Lifecare ASA: Updated company presentation | 4 | Oslo Børs | ||
| 03.04. | Lifecare ASA: Annual General Meeting | - | Oslo Børs | ||
| 28.03. | Lifecare ASA Annual Report 2024 | 1 | Oslo Børs | ||
| 25.03. | Lifecare ASA: LIFE: First positive indication of increased sensor sensitivity in ongoing longevity study | 3 | Oslo Børs | ||
| 20.03. | Lifecare ASA: Lifecare scientific updates: CGM symposium in Bergen, consensus recommendations from the Diabetes Technology Society and presentation of data at ATTD 2025 | 5 | Oslo Børs | ||
| 21.02. | Lifecare ASA: Deutlicher Umsatzrückgang und steigende Verluste im Jahresabschluss | 2 | IT BOLTWISE | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 20.02. | LIFE: Lifecare ASA Q4 2024 | 4 | Oslo Børs | ||
| 14.02. | Lifecare ASA: Financial calendar | 3 | Oslo Børs | ||
| 04.02. | Lifecare ASA: LIFE: Improved chemistry successfully tested in sensor | 4 | Oslo Børs | ||
| 16.01. | Lifecare ASA: Financial calendar | 2 | Oslo Børs | ||
| 14.01. | Lifecare ASA: LIFE Fivefold improvement of sensor chemistry sensitivity | 6 | Oslo Børs | ||
| 13.11.24 | LIFE: Lifecare ASA Q3 2024 | 3 | Oslo Børs | ||
| 05.11.24 | Lifecare ASA Q3 2024 presentation | 3 | Oslo Børs | ||
| 29.10.24 | Lifecare ASA: Lifecare - Sanofi Product Development Agreement Update | 22 | Oslo Børs | ||
| 21.10.24 | Nasdaq Stockholm AB: Admission to trading of Lifecare ASA on First North NOK | 261 | GlobeNewswire | Nasdaq Stockholm AB has admitted Lifecare ASA shares to trading on First North
NOK, with effect from October 22, 2024.
The shares will be traded on the First North NOK segment.
Short name: LIFEo... ► Artikel lesen | |
| 01.10.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 01.10.2024 | 759 | Xetra Newsboard | The following instruments on XETRA do have their first trading 01.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.10.2024
Aktien
1 CA09972D1069 Borealis Mining Co.... ► Artikel lesen | |
| 30.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.09.2024 | 403 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 30.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.09.2024ISIN Name
AU000000MCT4... ► Artikel lesen | |
| 30.09.24 | XFRA ISIN CHANGE | 778 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US10501E2019 Brainstorm Cell Therapeutics Inc. 30.09.2024 US10501E3009 Brainstorm Cell Therapeutics Inc. 01.10.2024 Tausch... ► Artikel lesen | |
| 20.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.05.2024 | 300 | Xetra Newsboard | Das Instrument 8OB SE0016844468 COMPODIUM INTL. AB EQUITY wird cum Kapitalmassnahme gehandelt am 20.05.2024 und ex Kapitalmassnahme am 21.05.2024 The instrument 8OB SE0016844468 COMPODIUM INTL. AB EQUITY... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 56,50 | -0,53 % | Roku Introduces New Device Line-Up: Buy, Sell or Hold the Stock? | ||
| SERNOVA BIOTHERAPEUTICS | 0,133 | +0,76 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 89,00 | 0,00 % | Boston Scientific: Jon Monson To Succeed Brennan As CFO | WASHINGTON (dpa-AFX) - Boston Scientific (BSX) announced that Dan Brennan, executive vice president and chief financial officer, has elected to retire. Brennan will transition out of the chief... ► Artikel lesen | |
| PAUL HARTMANN | 257,00 | +1,18 % | Paul Hartmann-Aktie // Gute Aussichten bei günstiger Bewertung | Paul Hartmann meldet ein erfolgreiches Geschäftsjahr 2024 und strebt für 2025 weitere Ergebnisverbesserung an. Die Aktie befindet sich in einer charttechnisch reizvollen Situation.
Quelle .. Den vollständigen... ► Artikel lesen | |
| SYSMEX | 16,100 | -2,42 % | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
| ADDLIFE | 14,080 | -1,88 % | AddLife AB: Year-end Report 1 January - 31 December 2024 | AddLife finishes the year with high growth, improved margins, and strong cash flow
"AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash... ► Artikel lesen | |
| EMBECTA | 10,200 | -1,92 % | Embecta Corp.: embecta to Report Fiscal Second Quarter 2025 Financial Results | ||
| ENOVIS | 28,000 | -9,68 % | Enovis Corporation: Enovis Announces Appointment of Damien McDonald as Chief Executive Officer | Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis Corporation... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 19.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.11.2024ISIN NameAU000000SVW5 SEVEN... ► Artikel lesen | |
| KANGJI MEDICAL | 0,800 | -1,23 % | KANGJI MEDICAL (09997): VOLUNTARY ANNOUNCEMENT - REGISTRATION APPROVAL FOR FOUR-ARM SURGICAL ROBOT OF WEIJING MEDICAL | ||
| PULMONX | 4,580 | +11,71 % | Pulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results | REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 11,800 | -1,67 % | SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance | SANTA CLARA, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the fourth... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,615 | +5,13 % | Peijia Medical Announces 2024 Annual Results | HONG KONG, March 26, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| KOOTH | 1,750 | +0,57 % | EARNINGS AND TRADING: Everyman Media loss widens; Kooth back in profit |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,004 (-0,53 %) liegt der Kurs bei 0,744 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.
